Alfred G. Gilman, a Nobel laureate who concluded his academic career in the role of chief scientific officer of the Cancer Prevention and Research Institute of Texas, died Dec. 23, 2015. Gilman, 74, had pancreatic cancer.
From a 2008 video produced by NCCS titled "Ellen Stovall: One Person Can Make a Difference," available below.
As the New Year approaches, we are preparing to revamp our website and launch an app. The work on it is almost done—a January launch seems likely.
FDA approved Bendeka (bendamustine hydrochloride) injection, a 10-minute infusion formulation of bendamustine.
RAYMOND DUBOIS was named the next dean of The Medical University of South Carolina College of Medicine. DuBois will assume his new role effective March 1, 2016, with an academic appointment as professor while also holding an appointment in the Hollings Cancer Center.
THE HEALTHWELL FOUNDATION launched a fund to provide financial assistance to underinsured patients suffering from multiple myeloma, providing grants up to $10,000 to assist patients with copayment or premium costs.
INDIANA UNIVERSITY MELVIN AND BREN SIMON CANCER CENTER is seeking high school and college applicants for its 2016 Summer Research Program.
Congress passed a $1.1 trillion government spending bill Friday morning, increasing the NIH budget by $2 billion. The measure now moves to the president's desk for approval.
THE KNIGHT CANCER INSTITUTE at Oregon Health & Science University and Cancer Research UK formed an international collaboration focused on the early detection of cancer.
Devices aren't tracked with the same rigor as drugs, because FDA does not have a data system that can reliably track medical devices and identify potential safety problems, according to Gregory Daniel, fellow and managing director of the Center for Health Policy at Brookings Institution.